These Exhibitor Product Theaters are promotional activities not approved for continuing education credit. The content of the Exhibitor Product Theaters and opinions expressed by presenters are those of the sponsor or presenter and are not of the San Antonio Breast Cancer Symposium® (SABCS).
Events
Discover What’s Possible in HER2+ Metastatic Breast Cancer: Pfizer’s Commitment to Patients and Innovation
Product Theater A.
Supported by Pfizer.
Don’t miss the latest data across treatment settings for ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Product Theater B
Supported By: Daiichi Sankyo, Inc. and AstraZeneca
Select Treatment Options for Appropriate Patients With Certain Types of TNBC
Product Theater B.
Supported by Merck.
Cerianna FES-PET in Practice: A Panel Discussion on ER+ Invasive Lobular Carcinoma
Product Theater A
Supported by GE Healthcare.
An Overview of VEPPANU (vepdegestrant) For 2L+ Treatment of ESR1m ER+/HER2- mBC
Product Theater A.
Supported by Rigel.
A Next-Generation 1L Approach in HR+/HER2− mBC: The Role of Early Intervention Upon Emergence of Endocrine Resistance
Product Theater B.
Supported by Astrazeneca.
Interrupt Progression: Using an Oral ER Antagonist and CDK4/6 Inhibitor Combination for Appropriate Patients
Product Theater A.
Supported by Eli Lilly.
Navigating the HR+/HER2- Breast Cancer Landscape: Insights for Clinical Practice
Product Theater B.
Supported by Novartis.
Highly Sensitive and Cost-Effective ESR1 Mutation Detection for Breast Cancer Research Applications
Product Theater A.
Supported by Bio-Rad.
Redefining Endocrine Therapy in Early HR+ Breast Cancer: Applying New Evidence and Emerging Strategies for Precision Care
Product Theater B.
Supported by Hologic.
The Trusted Leader in Breast Cancer Insights. Expanded. The Emerging Role of MRD and ctDNA Surveillance in HR+/HER2- Early Breast Cancer
Product Theater A.
Supported by Exact Sciences.
A 2L Treatment Option for HR+/HER2− aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i
Product Theater B.
Supported by Astrazeneca.

